Skip to main content
Clinical Trials/NCT06694714
NCT06694714
Recruiting
Phase 4

Characterizing and Comparing the Duration of Local Anesthetic in Dermatologic Surgery - Fourth Arm

Weill Medical College of Cornell University1 site in 1 country35 target enrollmentJanuary 21, 2025

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Weill Medical College of Cornell University
Enrollment
35
Locations
1
Primary Endpoint
Time to Return to Baseline Sensation, as Determined by Binary Outcomes (Yes/no) in 15 Minute Increments
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

This is a research study to compare how long injectable pain medications (anesthetics) commonly used in dermatologic surgery are effective for. The investigators will investigate the role of anesthetic volume on the duration of action at highly vascular sites.

Detailed Description

The investigators seek to further investigate how the vascularity of an anatomical region influences the duration of local anesthetics during dermatologic surgery. The investigators hypothesize that regional vascularity, by increasing the rate of uptake and removal of the anesthetic from the infiltrated site, will significantly reduce the duration of action of increased doses of infiltrative anesthesia. Specifically, the investigators will compare the duration of a commonly used local anesthetic (lidocaine ± epinephrine) injected at two different volumes at the nasal ala. The investigators will use a modification of a previously published approach of non-invasive pinprick testing to assess the duration of local anesthesia. The investigators aim to demonstrate that there will be no clinically significant difference in the duration of action of varying volumes of the same local anesthetic injected at bilateral areas of the face. This study record uses the same protocol document of a previous study under Clinical Trials record NCT05767749, but documents a fourth arm for which data will be analyzed separately from data in NCT05767749

Registry
clinicaltrials.gov
Start Date
January 21, 2025
End Date
June 1, 2027
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female ≥ 18 years of age
  • Normal skin sensation at both nasal ala assessed by pinprick
  • Ability to provide informed consent

Exclusion Criteria

  • Previous adverse reaction to local anesthetic or any components of the local anesthetics being evaluated
  • Pregnant or breastfeeding volunteers (assessed by self-report)
  • Patients taking monoamineoxidase inhibitors (MAOI) or antidepressants of the triptyline or imipramine types

Outcomes

Primary Outcomes

Time to Return to Baseline Sensation, as Determined by Binary Outcomes (Yes/no) in 15 Minute Increments

Time Frame: Up to 4 hours.

To determine whether the time to return to baseline sensation differs significantly between each pair of anesthetics, the investigators will measure the time to return to baseline sensation at each anesthetized site by asking participants at 15 minute intervals if they can feel a sharp sensation at the site. Sterile needles will be used. The return of the sensitivity will be determined using binary outcomes (yes/no) and recorded on a standardized template. The maximum difference in anesthetic duration that the investigators consider "not different" from a clinical standpoint is 15 minutes.

Study Sites (1)

Loading locations...

Similar Trials